Document Detail


Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil.
MedLine Citation:
PMID:  15200273     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty mature male Wistar rats were maintained alive for 40 days, separated in four groups of five rats each: control, L-NAME (LN), L-NAME + Enalapril (LN + E), L-NAME + Verapamil (LN + V). Blood pressure (BP), left ventricular (LV) mass index, and aortic wall parameters were analyzed: aortic wall thickness, tunica media sectional area, surface density of lamellae (Sv[lamellae]), and smooth muscle cell nuclear profiles per section (SMC). At the end of the experiment, the LN group showed high BP and a high LV mass index (cardiac hypertrophy). The control group and the other groups showed significant differences in aortic wall thickness, tunica media sectional area, Sv[lamellae], and SMC. When comparing the LN group with both the LN + E group and the LN + V group, aortic thickness was not different. Tunica media sectional area and SMC differed between the LN group and the LN + E group. There were also differences between the LN group and the LN + V group in SMC. The Sv[lamellae] decreased in the following sequence: control group > LN group = LN + E group > LN + V group. In conclusion, treatment with enalapril and verapamil shows partial efficiency in preventing or treating aortic wall tunica media hypertrophy, suggesting that these alterations are due to a mechanism other than blood pressure control, where nitric oxide synthesis inhibition could be involved.
Authors:
Leila M M Pereira; Daniele G Bezerra; Carlos A Mandarim-de-Lacerda
Related Documents :
8599253 - Effects of dexamethasone on laryngeal edema following short-term intubation.
8688263 - Comparison of the effects of urapidil and sodium nitroprusside on haemodynamic state, m...
17666193 - Prevention of stroke in patients with hypertension.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pathology, research and practice     Volume:  200     ISSN:  0344-0338     ISO Abbreviation:  Pathol. Res. Pract.     Publication Date:  2004  
Date Detail:
Created Date:  2004-06-17     Completed Date:  2004-12-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7806109     Medline TA:  Pathol Res Pract     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  211-7     Citation Subset:  IM    
Affiliation:
Laboratório de Morfometria & Morfologia Cardiovascular, Universidade do Estado do Rio de Janeiro, Centro Biomédico, Av 28 de Setembro, 87 fds. CEP:20551-030, Rio de Janeiro, RJ, Brazil. mandarim@uerj.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Animals
Aorta, Thoracic / drug effects,  pathology*
Blood Pressure / drug effects
Calcium Channel Blockers / pharmacology*
Disease Models, Animal
Drug Therapy, Combination
Enalapril / pharmacology*
Heart Ventricles / drug effects,  pathology
Male
Muscle, Smooth, Vascular / drug effects,  metabolism,  pathology
NG-Nitroarginine Methyl Ester / pharmacology
Nitric Oxide / deficiency*
Rats
Rats, Wistar
Verapamil / pharmacology*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Calcium Channel Blockers; 10102-43-9/Nitric Oxide; 50903-99-6/NG-Nitroarginine Methyl Ester; 52-53-9/Verapamil; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduced expression of aquaporin 4 in human muscles with amyotrophic lateral sclerosis and other neur...
Next Document:  Application of stereological methods for the quantification of VCAM-1 and ICAM-1 expression in early...